‘Female viagra’ fails to arouse, causes dizziness
Despite missing that goal, the Food and Drug Administration said women did report slightly more satisfaction in their sexual experiences.
Boehringer Ingelheim has asked the FDA to approve its drug flibanserin for women who report a lack of sexual desire, a market that drug makers have been targeting for more than a decade since the success of Viagra in men.
